AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 37 filers reported holding AXSOME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $252,529 | +21.1% | 3,137 | +20.0% | 0.00% | – |
| Q1 2024 | $208,597 | -4.0% | 2,614 | -4.2% | 0.00% | -100.0% |
| Q4 2023 | $217,201 | -63.4% | 2,729 | -88.1% | 0.00% | -85.7% |
| Q2 2019 | $593,000 | +93.8% | 23,025 | +7.0% | 0.01% | +75.0% |
| Q1 2019 | $306,000 | +161.5% | 21,525 | -48.2% | 0.00% | +100.0% |
| Q4 2018 | $117,000 | -18.2% | 41,525 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $143,000 | +7.5% | 41,525 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $133,000 | +30.4% | 41,525 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $102,000 | -56.2% | 41,525 | 0.0% | 0.00% | -55.6% |
| Q4 2017 | $233,000 | +1.3% | 41,525 | 0.0% | 0.01% | -10.0% |
| Q3 2017 | $230,000 | +0.9% | 41,525 | 0.0% | 0.01% | -9.1% |
| Q2 2017 | $228,000 | +27.4% | 41,525 | -9.7% | 0.01% | +37.5% |
| Q1 2017 | $179,000 | -41.1% | 46,000 | +2.2% | 0.01% | -42.9% |
| Q4 2016 | $304,000 | -14.4% | 45,000 | 0.0% | 0.01% | -17.6% |
| Q3 2016 | $355,000 | +13.4% | 45,000 | +8.4% | 0.02% | 0.0% |
| Q2 2016 | $313,000 | – | 41,525 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |